136 related articles for article (PubMed ID: 37004428)
1. Efficacy evaluation of a novel oral silica-based vaccine in inducing mucosal immunity against Mycoplasma hyopneumoniae.
Ferreira GC; Sanches TVC; Mechler-Dreibi ML; Almeida HMS; Storino GY; Sonalio K; Petri FAM; Martins TS; Cides da Silva LC; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Res Vet Sci; 2023 May; 158():141-150. PubMed ID: 37004428
[TBL] [Abstract][Full Text] [Related]
2. Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control
Storino GY; Petri FAM; Mechler-Dreibi ML; Aguiar GA; Toledo LT; Arruda LP; Malcher CS; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047564
[No Abstract] [Full Text] [Related]
3. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
[TBL] [Abstract][Full Text] [Related]
4. Oral Immunization with Attenuated
Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
[TBL] [Abstract][Full Text] [Related]
5. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
7. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
[TBL] [Abstract][Full Text] [Related]
8. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
9. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
10. Different local, innate and adaptive immune responses are induced by two commercial
Beuckelaere L; Haspeslagh M; Biebaut E; Boyen F; Haesebrouck F; Krejci R; Meyer E; Gleerup D; De Spiegelaere W; Devriendt B; Maes D
Front Immunol; 2022; 13():1015525. PubMed ID: 36569943
[TBL] [Abstract][Full Text] [Related]
11. Experimental evaluation of
Kim S; Oh T; Yang S; Cho H; Chae C
Can J Vet Res; 2021 Jan; 85(1):77-81. PubMed ID: 33390658
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
[TBL] [Abstract][Full Text] [Related]
13. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
Park SJ; Seo HW; Park C; Chae C
Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of a live attenuated Mycoplasma hyopneumoniae vaccine with an ISCOM-matrix adjuvant in pigs.
Xiong Q; Wei Y; Feng Z; Gan Y; Liu Z; Liu M; Bai F; Shao G
Vet J; 2014 Feb; 199(2):268-74. PubMed ID: 24314715
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
[TBL] [Abstract][Full Text] [Related]
16. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.
Maes D; Boyen F; Devriendt B; Kuhnert P; Summerfield A; Haesebrouck F
Vet Res; 2021 May; 52(1):67. PubMed ID: 33964969
[TBL] [Abstract][Full Text] [Related]
17. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
[TBL] [Abstract][Full Text] [Related]
18. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma hyopneumoniae: from disease to vaccine development.
Simionatto S; Marchioro SB; Maes D; Dellagostin OA
Vet Microbiol; 2013 Aug; 165(3-4):234-42. PubMed ID: 23680109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
